The impact of ovarian cancer heterogeneity and microenvironment on organoid based drug sensitivity assessment
2020/37/B/NZ5/01984
Keywords
Descriptors
- NZ5_007: Leczenie chorób człowieka
- NZ5_005: Diagnostyka chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Medyczny w Lublinie, Wydział Lekarski
Voivodeship: lubelskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 5
Call
OPUS 19 – announced on 2020-03-16
- Amount awarded
- 1 951 517 PLN
- Project start date
- 2021-03-01
- Project end date
- 2025-02-28
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy
- Authors:
- Alicja Rajtak, Marta Ostrowska-Leśko, Klaudia Żak, Rafał Tarkowski, Jan Kotarski, Karolina Okła
- Academic press:
- Frontiers in Immunology (year: 2022, volume: 13, pages: nie dotyczy), Publisher: Frontiers
- Status:
- Published
- DOI:
- 10.3389/fimmu.2022.1018256 – link to the publication
-
Clinical Relevance of Mortalin in Ovarian Cancer Patients
- Authors:
- Alicja Rajtak, Arkadiusz Czerwonka, Michael Pitter , Jan Kotarski, Karolina Okła
- Academic press:
- Cells (year: 2023, volume: 12 issue 5, pages: nie dotyczy), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/cells12050701 – link to the publication